Open access
137
Views
14
CrossRef citations to date
0
Altmetric
Original Research
Cost-effectiveness of rosuvastatin in comparison with generic atorvastatin and simvastatin in a Swedish population at high risk of cardiovascular events
Sanjay K Gandhi1 AstraZeneca LP, Wilmington, DE, USACorrespondence[email protected]
, Marie M Jensen2 AstraZeneca, Lund, Sweden
, Kathleen M Fox3 Strategic HealthCare Solution, Monkton, MD
, Lee Smolen4 Medical Decision Modeling Inc, Indianapolis, IN, USA
, Anders G Olsson5 Department of Medical and Health Sciences, Linkoping University, and Stockholm Heart Center, Stockholm
& Thomas Paulsson6 AstraZeneca, Sodertalje, Sweden
Pages 1-11
|
Published online: 10 Jan 2012
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.